Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Adjuvant Phase III Trial of Six Cycles of Docetaxel+Hormonal Treatment Versus Hormonal Treatment in Patients With Intermediate or High-risk Prostate Cancer Treated With Radical Radiotherapy

NCT00653848 is registered in ClinicalTrials.gov with Scandinavian Prostate Cancer Group as lead sponsor.

NCT NCT00653848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00653848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Adjuvant Phase III Trial of Six Cycles of Docetaxel+Hormonal Treatment Versus Hormonal Treatment in Patients With Intermediate or High-risk Prostate Cancer Treated With Radical Radiotherapy
Lead sponsor
Scandinavian Prostate Cancer Group
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2007
Completion date
August 30, 2023
Enrollment
378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer